JK BioPharma Solutions Inc 13D and 13G filings for NeuroBo Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-09-23 4:20 pm Sale | 2022-09-13 | 13D | NeuroBo Pharmaceuticals, Inc. NRBO | JK BioPharma Solutions Inc | 0 0.000% | -10,908 (Position Closed) | Filing |
| 2021-11-10 2:17 pm Unchanged | 2021-10-05 | 13D | NeuroBo Pharmaceuticals, Inc. NRBO | JK BioPharma Solutions Inc | 10,908 9.800% | 0 (Unchanged) | Filing |